Celestica Inc. (CLS) financials
NYSE · Technology · Hardware, Equipment & Parts · 23,803 employees · CEO Robert Andrew Mionis
- Price
- $265.53 -6.09%
- Market cap
- $33.5B
- Enterprise value
- $30.2B
- Last report
- Q3 '26 filed 2026-10-26
- Next report
- 2027-01-27 EPS est. $3.53
Valuation & key figures
- Market cap
- $33.5B EV $30.2B
- Revenue
- $18.2B Trailing 12 months
- Revenue growth
- +70% FY2026 consensus
- Profit margin
- 6.8% Net income / revenue, TTM
- P/E
- 24.6× Forward 23.0× (FY2026)
- P/S
- 1.8× Price / sales, TTM
- EV / EBITDA
- 17.6× TTM
- Free cash flow
- $545M Trailing 12 months
- Net income
- $1.25B Trailing 12 months
- Revenue estimate
- $21B FY2026 consensus
- Earnings
- 2027-01-27 Revenue est. $6.47B
- Dividend
- – No dividend
Key takeaways
Computed from the reported numbers - every statement carries the figure it rests on.
- Last report (2026-10-26): revenue beat by 6.5%, EPS beat by 9.3%Revenue $5.75B vs $5.39B expected (+6.5%); EPS $3.30 vs $3.02 (+9.3%).
- Revenue growth accelerating: 82.5% year on yearQ3 '26 revenue $5.83B, against an average of 46.6% over the four quarters before.
- Operating margin 8.3% (TTM), +0.1 pp on a year agoOperating income grew 63.2% while revenue grew 61.6%.
- Capex 4.7% of revenue (a year ago 1.4%)$862M invested in the last 4 quarters (+459.4% on a year earlier). Free cash flow $545M = 43.8% of net income.
- Returned $96M to shareholders = 17.6% of free cash flowBuybacks $96M (a year earlier $143M), dividends $0, stock-based pay $84.1M (TTM).
- Diluted share count up 5.1% in a year122M diluted shares in Q3 '26, 116M a year earlier.
- Net cash $3.14BCash + short-term investments $3.96B, debt incl. leases $819M; a year ago net debt $615M.
- CCS Segment: revenue +101.9%, margin 8.9% (was 8.3%)Fastest-growing reported segment in Q3 '26: operating income $433M on revenue $4.87B (from the segment note of the filing).
Last quarter: Q3 '26
Quarter ended 2026-09-30. Compared with the same quarter a year earlier and with the analyst consensus before the report.
Quarter vs a year ago
| Q3 '26 | Year ago | Change | |
|---|---|---|---|
| Revenue | $5.83B | $3.19B | +82.5% |
| Gross margin | 11.0% | 13.0% | -2.0 pp |
| Operating income | $460M | $330M | +39.4% |
| Operating margin | 7.9% | 10.3% | -2.4 pp |
| Net income | $397M | $268M | +48.3% |
| Diluted EPS | $3.26 | $2.28 | +43.0% |
| Operating cash flow | $390M | $126M | +208.8% |
| Capex | $274M | $37.3M | +634.9% |
| Free cash flow | $116M | $88.9M | +30.0% |
| R&D | $51.2M | $36.4M | +40.7% |
| Stock-based compensation | $21.3M | $15.6M | +36.5% |
Reported vs consensus
2026-10-26| Actual | Consensus | vs consensus | |
|---|---|---|---|
| Revenue | $5.75B | $5.39B | +6.5% |
| EPS (as estimated) | $3.30 | $3.02 | +9.3% |
From the report of 2026-10-26 for Q3 '26: revenue and the EPS analysts estimate (often adjusted), so it can differ from the EPS of the statements above.
EPS vs consensus
last 8 reportsRevenue
Where the money comes from - by business line and by region, quarter by quarter.
Revenue, operating income and growth
quarterlyRevenue by business line
stacked, quarterly| Segment | Q3 '26 | y/y | Share | TTM | TTM y/y | 12 quarters |
|---|---|---|---|---|---|---|
| CCS | – | – | – | – | – | |
| ATS Segment | $957M | +22.6% | 100.0% | – | – | |
| ATS | – | – | – | – | – |
Segment profits
Operating income per reported segment, read from the segment note of each 10-Q / 10-K (the profit split most data feeds leave out).
Segments in Q3 '26
| Segment | Revenue | y/y | Operating income | y/y | Margin | Margin a year ago | TTM operating income |
|---|---|---|---|---|---|---|---|
| CCS Segment | $4.87B | +101.9% | $433M | +117.3% | 8.9% | 8.3% | $1.28B |
| ATS Segment | $957M | +22.6% | $62.9M | +47.0% | 6.6% | 5.5% | $209M |
Operating income by segment
quarterlySegment operating margin
quarterlyFourth quarters are derived: the 10-K reports the full year, minus the three quarters of the 10-Qs.
Margins & cost structure
How much of each unit of revenue is left at each level - and where the costs go.
Margins
quarterlyCosts as % of revenue
quarterlyCash flow & capital allocation
Cash generated, what it is spent on, and what reaches shareholders.
Operating cash flow, capex, free cash flow
quarterlyUses of cash vs operating cash flow
fiscal yearsLast 4 quarters
cash flow statement- Operating cash flow
- $1.41B
- Capex
- -$862M
- Buybacks
- -$96M
- Dividends
- $0
- Acquisitions
- $48.8K
- Net debt issued
- -$3.7M
- Stock-based compensation
- $84.1M
- Free cash flow
- $545M
- Returned to shareholders / FCF
- 17.6%
Share count and EPS
quarterly, dilutedBalance sheet
Liquidity, investments and debt at each quarter end.
Cash, investments and debt
quarter endsValuation & returns
Today's multiples against the company's own last five fiscal years; analyst targets and ratings.
Multiples and returns
TTM vs 5 fiscal years| Now | 5y average | Where today sits in the 5-year range | |
|---|---|---|---|
| P/E (TTM) | 24.6× | 20.3× | 7.7× – 40.2× |
| EV / EBITDA | 17.6× | 12.4× | 4.4× – 28.4× |
| EV / Sales | 1.7× | 1.0× | 0.2× – 2.8× |
| Price / FCF | 61.1× | 29.9× | 8.1× – 74.4× |
| Price / Book | 5.1× | 5.0× | 0.8× – 15.4× |
| FCF yield | 1.6% | 5.9% | 1.3% – 12.4% |
| Return on invested capital | 17.5% | 13.4% | 5.2% – 27.3% |
| Return on equity | 38.3% | 18.4% | 7.1% – 37.6% |
Analysts
Consensus target $449.90 (+69.4%)
range $375.00 – $520.00 · rating Buy
Outlook
Analyst consensus for the coming fiscal years and what it implies at today's price.
Consensus estimates
| Fiscal year | Revenue | Growth | EPS | Growth | P/E at today's price | Analysts (EPS) |
|---|---|---|---|---|---|---|
| FY2026 | $21B | +69.5% | $11.55 | +58.4% | 23.0× | 10 |
| FY2027 | $39.6B | +88.7% | $21.98 | +90.3% | 12.1× | 6 |
| FY2028 | $57.3B | +44.5% | $32.00 | +45.6% | 8.3× | 6 |
| FY2029 | $70.1B | +22.4% | $39.51 | +23.5% | 6.7× | 3 |
| FY2030 | $84.2B | +20.1% | $47.79 | +21.0% | 5.6× | 2 |
Financial statements
Every line of the income statement, balance sheet and cash flow statement - 12 quarters and 10 fiscal years, as values, as % of revenue or as growth.
Every reported line
All 226 figures Celestica Inc. tagged in its recent 10-Q / 10-K filings, with the official SEC label and definition - including the notes (leases, taxes, buybacks, employees, ...).
| Line (SEC label) | Latest quarter | Year ago | y/y | Latest FY | Prior FY | y/y |
|---|---|---|---|---|---|---|
| Accounts and Other Receivables, Net, Current | $3.76B | $2.44B | +54.3% | $2.64B | $2.07B | +27.5% |
| Accounts Payable, Current | $5.04B | $1.68B | +200.1% | $1.87B | $1.29B | +44.1% |
| Accounts Receivable, Allowance for Credit Loss, Current | $35.9M | $29.5M | +21.7% | $30.5M | $10.1M | +202.0% |
| Accounts Receivable, Credit Loss Expense (Reversal) | – | – | – | $18.2M | $2.8M | +550.0% |
| Accrued Income Taxes, Current | $143M | $122M | +17.1% | $151M | $93.5M | +61.2% |
| Accrued Liabilities, Current | $1.51B | – | – | – | – | – |
| Accumulated Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Tax | -$28.2M2025-12-31 | -$25.9M | -8.9% | -$28.2M | -$25.9M | -8.9% |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | -$1.7M2025-12-31 | -$17.6M | +90.3% | -$1.7M | -$17.6M | +90.3% |
| Additional Paid in Capital, Common Stock | $343M2025-12-31 | $798M | -57.0% | $343M | $798M | -57.0% |
| Amortization of Intangible Assets | $10.5M | $11.4M | -7.9% | $45.6M | $43.5M | +4.8% |
| APIC, Share-based Payment Arrangement, Increase for Cost Recognition | -$25.4M | $15.5M | -263.9% | -$154M | -$25.3M | -506.7% |
| Assets | $15.1B | $6.61B | +129.1% | $7.21B | $5.99B | +20.5% |
| Assets for Plan Benefits, Defined Benefit Plan | $9.7M2025-12-31 | $10M | -3.0% | $9.7M | $10M | -3.0% |
| Assets, Current | $12.5B | $5.14B | +143.9% | $5.67B | $4.51B | +25.7% |
| Business Combination, Acquisition Related Costs | $0 | $300K | -100.0% | $1.6M | $2.5M | -36.0% |
| Capital Expenditures Incurred but Not yet Paid | $238M | $24.4M | +876.6% | $59.4M | $29.7M | +100.0% |
| Cash | $574M2025-12-31 | $415M | +38.2% | $574M | $415M | +38.2% |
| Cash and Cash Equivalents, at Carrying Value | $3.96B | $306M | +1,195.0% | $596M | $423M | +40.7% |
| Cash Equivalents, at Carrying Value | $21.4M2025-12-31 | $7.9M | +170.9% | $21.4M | $7.9M | +170.9% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $3.96B | $306M | +1,195.0% | $596M | $423M | +40.7% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | $3.43B | -$7.9M | +43,462.0% | $172M | $52.9M | +225.7% |
| Common Stock, Shares, Issued | 115M2025-12-31 | 116M | -1.0% | 115M | 116M | -1.0% |
| Common Stock, Shares, Outstanding | 115M2025-12-31 | 116M | -1.0% | 115M | 116M | -1.0% |
| Common Stock, Value, Issued | $1.62B2025-12-31 | $1.63B | -0.8% | $1.62B | $1.63B | -0.8% |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent | $406M | $255M | +59.1% | $848M | $411M | +106.6% |
| Contract with Customer, Asset, after Allowance for Credit Loss, Current | $417M | $304M | +37.4% | $296M | $238M | +24.5% |
| Contract with Customer, Liability, Current | $481M2026-06-30 | $397M | +21.4% | $407M | $512M | -20.4% |
| Cost of Goods and Services Sold | $5.19B | $2.78B | +86.8% | $10.9B | $8.61B | +26.5% |
| Current Federal Tax Expense (Benefit) | – | – | – | $200K | – | – |
| Current Federal, State and Local, Tax Expense (Benefit) | – | – | – | $200K | $1.5M | -86.7% |
| Current Foreign Tax Expense (Benefit) | – | – | – | $219M | $135M | +62.6% |
| Current Income Tax Expense (Benefit) | $84.8M | $44.2M | +91.9% | $219M | $136M | +61.0% |
| Debt Issuance Costs, Noncurrent, Net | $2.3M2025-12-31 | $3.3M | -30.3% | $2.3M | $3.3M | -30.3% |
| Deferred Federal, State and Local, Tax Expense (Benefit) | – | – | – | $0 | $0 | – |
| Deferred Foreign Income Tax Expense (Benefit) | – | – | – | -$68.4M | -$31.9M | -114.4% |
| Deferred Income Tax Assets, Net | $233M | $99.5M | +133.7% | $156M | $87.7M | +78.3% |
| Deferred Income Tax Expense (Benefit) | -$26.2M | -$1.1M | -2,281.8% | -$68.4M | -$31.9M | -114.4% |
| Deferred Income Tax Liabilities, Net | $39.9M | $45.1M | -11.5% | $41.2M | $49.4M | -16.6% |
| Deferred Income Taxes and Tax Credits | – | – | – | -$68.4M | -$31.9M | -114.4% |
| Deferred Tax Assets, Gross | $490M2025-12-31 | $491M | -0.1% | $490M | $491M | -0.1% |
| Deferred Tax Assets, Net | $115M2025-12-31 | $38.3M | +200.8% | $115M | $38.3M | +200.8% |
| Deferred Tax Assets, Net of Valuation Allowance | $137M2025-12-31 | $105M | +30.7% | $137M | $105M | +30.7% |
| Deferred Tax Assets, Other | $77.8M2025-12-31 | $60.8M | +28.0% | $77.8M | $60.8M | +28.0% |
| Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits | $22.3M2025-12-31 | $7.6M | +193.4% | $22.3M | $7.6M | +193.4% |
| Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals | $136M2025-12-31 | $65.1M | +108.4% | $136M | $65.1M | +108.4% |
| Deferred Tax Assets, Valuation Allowance | $354M2025-12-31 | $386M | -8.4% | $354M | $386M | -8.4% |
| Deferred Tax Liabilities, Gross | $21.6M2025-12-31 | $66.4M | -67.5% | $21.6M | $66.4M | -67.5% |
| Deferred Tax Liabilities, Unrealized Currency Transaction Gains | $21.6M2025-12-31 | $16.4M | +31.7% | $21.6M | $16.4M | +31.7% |
| Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position | -$84.8M2025-12-31 | -$77.8M | -9.0% | -$84.8M | -$77.8M | -9.0% |
| Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage | 100.0%2025-12-31 | 100.0% | 0.0% | 100.0% | 100.0% | 0.0% |
| Defined Benefit Plan, Plan Assets, Amount | $203M2025-12-31 | $191M | +6.2% | $203M | $191M | +6.2% |
| Depreciation | – | – | – | $130M | $108M | +20.1% |
| Depreciation, Depletion and Amortization | $48.5M | $40.3M | +20.3% | $176M | $152M | +15.7% |
| Derivative Asset, Noncurrent | $400K2025-12-31 | $0 | – | $400K | $0 | – |
| Derivative, Gain (Loss) on Derivative, Net | -$3.9M | $113M | -103.4% | $253M | $91M | +178.0% |
| Earnings Per Share, Basic | $3.30 | $2.33 | +41.6% | $7.22 | $3.62 | +99.4% |
| Earnings Per Share, Diluted | $3.26 | $2.31 | +41.1% | $7.16 | $3.61 | +98.3% |
| Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | – | – | – | $141M2024-12-31 | $81.1M | +73.9% |
| Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | – | – | – | 245,800,000 CAD | – | – |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | – | – | – | 25.0% | 26.5% | -5.7% |
Source: SEC companyfacts (XBRL of every 10-Q / 10-K). Cash-flow quarters are derived from the year-to-date figures the 10-Q tags. Segment breakdowns are tagged with dimensions and are shown in the segment section instead.
Sources
Statements, segment revenue, metrics and estimates are standardised from the company's filings. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-09-30, 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31
Data as of 2026-11-02